Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study-Reference-Cited by-同舟云学术

Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study

Published:2011-05-06 Issue:8 Volume:60 Page:1097-1107
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Bauer Christian,Dauer Marc,Saraj Samira,Schnurr Maximilian,Bauernfeind Franz,Sterzik Alexander,Junkmann Jana,Jakl Veronika,Kiefl Rosemarie,Oduncu Fuat,Emmerich Bertold,Mayr Doris,Mussack Thomas,Bruns Christiane,Rüttinger Dominik,Conrad Claudius,Jauch Karl-Walter,Endres Stefan,Eigler Andreas

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-011-1023-5.pdf

Reference29 articles.

1. Ozols RF, Herbst RS, Colson YL, Gralow J, Bonner J, Curran WJ Jr, Eisenberg BL, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Reaman GH, Sawaya R, Schilsky RL, Schuchter LM, Sweetenham JW, Vahdat LT, Winn RJ (2007) Clinical cancer advances 2006: Major research advances in cancer treatment, prevention, and screening–a report from the American society of clinical oncology. J Clin Oncol 25(1):146–162. doi: 10.1200/JCO.2006.09.7030

2. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403–2413

3. Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA 3rd, Green MR, Tarassoff PG, Brown TD, Casper ES, Storniolo AM, Von Hoff DD (1996) A phase ii trial of gemcitabine in patients with 5-fu-refractory pancreas cancer. Ann Oncol 7(4):347–353

4. Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, Andre T, Zaniboni A, Ducreux M, Aitini E, Taieb J, Faroux R, Lepere C, de Gramont A (2005) Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: Results of a gercor and giscad phase iii trial. J Clin Oncol 23(15):3509. doi: 10.1200/JCO.2005.06.023

5. Dauer M, Schnurr M, Eigler A (2008) Dendritic cell-based cancer vaccination: Quo vadis? Expert Rev Vaccines 7(7):1041–1053. doi: 10.1586/14760584.7.7.1041

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations;Current Oncology;2024-08-23

2. Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation;Biomedical Journal;2023-12

3. Dendritic Cell as Potential Immunotherapy for Nasopharyngeal Cancer: A Review;The Indonesian Biomedical Journal;2023-10-18

4. The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: unravelling challenges and opportunities;The Journal of Pathology;2023-08

5. IL18 Receptor Signaling Inhibits Intratumoral CD8+ T-Cell Migration in a Murine Pancreatic Cancer Model;Cells;2023-01-31